Clinical Immunology Service
Organisational unit: Department
Research Projects
COV-AD: Covid infection in patients with antibody deficiency
MEDICAL RESEARCH COUNCIL
1/02/21 → 31/07/22
Project: Research Councils
OCTAVE: Observational patient Cohorts-T-cells Antibodies and Vaccine Efficacy in SARS-CoV-2
Daniel Rea, Paul Moss, Pamela Kearns, Amanda Kirkham, Alex Richter &
MEDICAL RESEARCH COUNCIL
1/01/21 → 31/01/22
Project: Research
The influence of psychosocial and lifestyle factors on immune health and injury incidence during phase one training in UK Army recruits
MINISTRY OF DEFENCE
1/12/20 → 30/11/21
Project: Other Government Departments
Longitudinal population-based observational study of coronavirus disease in the UK population
Barts Charity
1/11/20 → 31/10/25
Project: Research
Protective Immunity from T cells to Covid-19 in Health workers - a pragmatic add-on study to SIREN
DEPARTMENT OF HEALTH & SOCIAL CARE
1/11/20 → 31/10/21
Project: Other Government Departments
Can the measurement of anti-SARS-CoV-2 salivary antibodies enhance the sensitivity of seroprevalence studies and are these antibody responses clinically relevant?
Association for Clinical Biochemistry and Laboratory Medicine
1/09/20 → 31/08/21
Project: Research
Understanding the contribution of occupational exposures to risk of COVID-19 infection and approaches to control among healthcare workers in Birmingham
Elizabeth Sapey, Steven Sadhra, Raoul Reulen, Alice Sitch, KK Cheng, Ruth Riley, Kiran Rai, Alex Richter, Rachel Jordan & Peymane Adab
MEDICAL RESEARCH COUNCIL
1/08/20 → 31/07/21
Project: Research Councils
BREATHE – B cell Receptor Evaluation for Antibodies to protect Human Exposure to SARS-CoV-2
Dagmar Scheel-Toellner & Alex Richter
Alchemab Therapeutics Ltd
1/07/20 → 30/06/21
Project: Research
Assessment of 5T4 Expression in AML and CLL by Flow Cytometry and Determination of T cell Fitness and Tumour Antigen Expression in AML and CLL by CyTOF
Oxford Biomedica Plc.
1/06/20 → 14/12/20
Project: Research
MRC CiC: A new technique to measure minimal residual disease in myeloma that offers superior sensitivity, reduced cost and patient benefits
Jennifer Heaney & Mark Drayson
MEDICAL RESEARCH COUNCIL
1/03/20 → 30/06/21
Project: Research Councils